We have two R&D centers located in Lianyungang and Shanghai. Our in-house R&D activities span the entire R&D process, including chemical compound design and screening, pharmacological and toxicological studies, CMC, as well as clinical development, which have ensured our high efficiency in developing new drugs. We have national-level research and development designations, including the National Technology Center, Post-doctoral Research Station, and Key National Laboratory, including the National and Local Joint Center for Biopharmaceutical Development, the Academician Workstation of Jiangsu, the Technology Research Center for Gastrointestinal Pharmaceutical in Jiangsu, and established long-term cooperative relationships with a number of domestic research institutes.
We focus on clinical-need based and market oriented R&D, which targets and identifies pharmaceuticals that have the potential for gaining widespread market acceptance within China’s fastest growing, large and underserved therapeutic areas, such as CNS, oncology, anti-infectives, diabetes, gastrointestinal, cardiovascular, and so on.
We have a proven track record of over 20 years of R&D experience. Our dedicated professional R&D team consisted of over 1,200 full-time employees,approximately 400 of whom hold a master’s degree or above. One of them is entitled to special subsidies from the State Council. Other top talents include those who are part of the Jiangsu Program for Entrepreneurial and Innovative Talents and Jiangsu Program for 333 Talents. Our well-structured R&D team ensures the high efficiency of various R&D programs.